Drug tolerance and persistence to EGFR inhibitor treatment are mediated by an ILK-SFK-YAP signaling axis in lung adenocarcinoma. - Shi R; Farnsworth DA; Febres-Aldana CA; Chow JLM; Sheena R; Atwal T; Gomez Marti JL; Li S; Thomas KN; Lee CM; Awrey SJ; McDonald PC; et al. (Oncogene, 2025)